{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:27:29Z","timestamp":1786588049242,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82303623"],"award-info":[{"award-number":["82303623"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2023M731199"],"award-info":[{"award-number":["2023M731199"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Sponsored Postdoctoral Research Program of China","award":["GZB20230243"],"award-info":[{"award-number":["GZB20230243"]}]},{"name":"Postdoctoral Innovation Research Position in Hubei Province","award":["331048"],"award-info":[{"award-number":["331048"]}]},{"name":"Fundamental Research Funds for Central Universities","award":["YCJJ20241411"],"award-info":[{"award-number":["YCJJ20241411"]}]},{"name":"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology","award":["2022YBJ018"],"award-info":[{"award-number":["2022YBJ018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10142-026-02008-6","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T01:46:21Z","timestamp":1786585581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative multi-omics analysis identifies SMIM24 as a favorable prognostic biomarker in clear cell renal cell carcinoma"],"prefix":"10.1007","volume":"26","author":[{"given":"Zongyu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengjie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5459-5204","authenticated-orcid":false,"given":"Lilong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"2008_CR1","doi-asserted-by":"publisher","unstructured":"Bi K, He MX, Bakouny Z, Kanodia A, Napolitano S, Wu J, \u2026 Van Allen EM (2021) Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma. Cancer Cell 39(5):649\u2013661.e645. https:\/\/doi.org\/10.1016\/j.ccell.2021.02.015","DOI":"10.1016\/j.ccell.2021.02.015"},{"key":"2008_CR2","doi-asserted-by":"publisher","unstructured":"Braun DA, Hou Y, Bakouny Z, Ficial M, Sant\u2019 Angelo M, Forman J, \u2026 Choueiri TK (2020) Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma. Nat Med 26(6):909\u2013918. https:\/\/doi.org\/10.1038\/s41591-020-0839-y","DOI":"10.1038\/s41591-020-0839-y"},{"key":"2008_CR3","doi-asserted-by":"publisher","unstructured":"Brooks SA, Brannon AR, Parker JS, Fisher JC, Sen O, Kattan MW, \u2026 Rathmell WK (2014) ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol, 66(1): 77\u201384. https:\/\/doi.org\/10.1016\/j.eururo.2014.02.035","DOI":"10.1016\/j.eururo.2014.02.035"},{"key":"2008_CR4","doi-asserted-by":"publisher","unstructured":"B\u00fcttner FA, Winter S, St\u00fchler V, Rausch S, Hennenlotter J, F\u00fcssel S, \u2026 Schaeffeler E (2022) A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy. Genome Med 14(1):105. https:\/\/doi.org\/10.1186\/s13073-022-01105-y","DOI":"10.1186\/s13073-022-01105-y"},{"issue":"4","key":"2008_CR5","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41587-021-00830-w","volume":"40","author":"DM Cable","year":"2022","unstructured":"Cable DM, Murray E, Zou LS, Goeva A, Macosko EZ, Chen F, Irizarry RA (2022) Robust decomposition of cell type mixtures in spatial transcriptomics. Nat Biotechnol 40(4):517\u2013526. https:\/\/doi.org\/10.1038\/s41587-021-00830-w","journal-title":"Nat Biotechnol"},{"key":"2008_CR6","doi-asserted-by":"publisher","unstructured":"Chang Q, Zhao S, Sun J, Guo W, Yang L, Qiu L, \u2026 Liu J (2025) Identification of a novel prognostic and therapeutic prediction model in clear cell renal carcinoma based on Renin-angiotensin system related genes. Front Endocrinol (Lausanne) 16:1521940. https:\/\/doi.org\/10.3389\/fendo.2025.1521940","DOI":"10.3389\/fendo.2025.1521940"},{"key":"2008_CR7","doi-asserted-by":"publisher","unstructured":"Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, \u2026 Trajanoski Z (2017) Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep 18(1):248\u2013262. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.019","DOI":"10.1016\/j.celrep.2016.12.019"},{"key":"2008_CR8","doi-asserted-by":"publisher","unstructured":"Davidson G, Helleux A, Vano YA, Lindner V, Fattori A, Cerciat M, \u2026 Malouf GG (2023) Mesenchymal-like tumor cells and myofibroblastic cancer-associated fibroblasts are associated with progression and immunotherapy response of clear cell renal cell carcinoma. Cancer Res 83(17): 2952\u20132969. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-3034","DOI":"10.1158\/0008-5472.Can-22-3034"},{"issue":"2","key":"2008_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3892\/ol.2023.13663","volume":"25","author":"C Ding","year":"2023","unstructured":"Ding C, Yu Z, Li X, Zhu J, Dai M, He Q (2023) Collagen type VII \u03b11 chain: a promising prognostic and immune infiltration biomarker of pancreatic cancer. Oncol Lett 25(2):77. https:\/\/doi.org\/10.3892\/ol.2023.13663","journal-title":"Oncol Lett"},{"issue":"1","key":"2008_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-0721-z","volume":"12","author":"J Fu","year":"2020","unstructured":"Fu J, Li K, Zhang W, Wan C, Zhang J, Jiang P, Liu XS (2020) Large-scale public data reuse to model immunotherapy response and resistance. Genome Med 12(1):21. https:\/\/doi.org\/10.1186\/s13073-020-0721-z","journal-title":"Genome Med"},{"key":"2008_CR11","doi-asserted-by":"publisher","unstructured":"Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, \u2026 Ficarra V (2017) Renal cell carcinoma. Nat Rev Dis Primers 3:17009. https:\/\/doi.org\/10.1038\/nrdp.2017.9","DOI":"10.1038\/nrdp.2017.9"},{"key":"2008_CR12","doi-asserted-by":"publisher","unstructured":"Hu J, Wang SG, Hou Y, Chen Z, Liu L, Li R, \u2026 Chen K (2024) Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression. Nat Genet 56(3):442\u2013457. https:\/\/doi.org\/10.1038\/s41588-024-01662-5","DOI":"10.1038\/s41588-024-01662-5"},{"issue":"1","key":"2008_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.eururo.2024.04.001","volume":"86","author":"A Jiang","year":"2024","unstructured":"Jiang A, Qu L, Cai C, Luo P, Wang L (2024) Re: multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression. Eur Urol 86(1):76\u201377. https:\/\/doi.org\/10.1016\/j.eururo.2024.04.001","journal-title":"Eur Urol"},{"issue":"1","key":"2008_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","volume":"20","author":"S Jin","year":"2025","unstructured":"Jin S, Plikus MV, Nie Q (2025) Cell chat for systematic analysis of cell-cell communication from single-cell transcriptomics. Nat Protoc 20(1):180\u2013219. https:\/\/doi.org\/10.1038\/s41596-024-01045-4","journal-title":"Nat Protoc"},{"key":"2008_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15102701","author":"D Koca","year":"2023","unstructured":"Koca D, S\u00e9raudie I, Jardillier R, Cochet C, Filhol O, Guyon L (2023) COL7A1 expression improves prognosis prediction for patients with clear cell renal cell carcinoma atop of stage. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15102701","journal-title":"Cancers (Basel)"},{"issue":"2","key":"2008_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41585-024-00911-w","volume":"22","author":"KA Lawson","year":"2025","unstructured":"Lawson KA, Linehan WM (2025) De-clear cell differentiated renal cell carcinoma - a new therapeutic target. Nat Rev Urol 22(2):73\u201374. https:\/\/doi.org\/10.1038\/s41585-024-00911-w","journal-title":"Nat Rev Urol"},{"key":"2008_CR17","doi-asserted-by":"publisher","unstructured":"Li Y, Lih TM, Dhanasekaran SM, Mannan R, Chen L, Cieslik M, \u2026 Ding L (2023) Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness. Cancer Cell 41(1):139\u2013163.e117. https:\/\/doi.org\/10.1016\/j.ccell.2022.12.001","DOI":"10.1016\/j.ccell.2022.12.001"},{"key":"2008_CR18","doi-asserted-by":"publisher","unstructured":"Margue G, Ferrer L, Etchepare G, Bigot P, Bensalah K, Mejean A, \u2026 Bernhard JC (2024) UroPredict: Machine learning model on real-world data for prediction of kidney cancer recurrence (UroCCR-120). NPJ Precis Oncol 8(1):45. https:\/\/doi.org\/10.1038\/s41698-024-00532-x","DOI":"10.1038\/s41698-024-00532-x"},{"key":"2008_CR19","doi-asserted-by":"publisher","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, \u2026 Powles T (2018) TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554(7693):544\u2013548. https:\/\/doi.org\/10.1038\/nature25501","DOI":"10.1038\/nature25501"},{"issue":"4","key":"2008_CR20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis CS, Murrow LM, Gartner ZJ (2019) DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst 8(4):329-337.e324. https:\/\/doi.org\/10.1016\/j.cels.2019.03.003","journal-title":"Cell Syst"},{"key":"2008_CR21","doi-asserted-by":"publisher","unstructured":"De Meerleer G, Khoo V, Escudier B, Joniau S, Bossi A, Ost P, \u2026 Mareel M (2014) Radiotherapy for renal-cell carcinoma. Lancet Oncol 15(4):e170\u2013177. https:\/\/doi.org\/10.1016\/s1470-2045(13)70569-2","DOI":"10.1016\/s1470-2045(13)70569-2"},{"key":"2008_CR22","doi-asserted-by":"publisher","unstructured":"Motzer RJ, Banchereau R, Hamidi H, Powles T, McDermott D, Atkins MB, \u2026 Rini B (2020) Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade. Cancer Cell 38(6):803\u2013817.e804. https:\/\/doi.org\/10.1016\/j.ccell.2020.10.011","DOI":"10.1016\/j.ccell.2020.10.011"},{"key":"2008_CR23","doi-asserted-by":"publisher","unstructured":"Motzer RJ, Robbins PB, Powles T, Albiges L, Haanen JB, Larkin J, \u2026 Choueiri TK (2020) Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial. Nat Med 26(11):1733\u20131741. https:\/\/doi.org\/10.1038\/s41591-020-1044-8","DOI":"10.1038\/s41591-020-1044-8"},{"key":"2008_CR24","doi-asserted-by":"publisher","unstructured":"Motzer RJ, Jonasch E, Agarwal N, Alva A, Baine M, Beckermann K, \u2026 Motter A (2022) Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 20(1):71\u201390. https:\/\/doi.org\/10.6004\/jnccn.2022.0001","DOI":"10.6004\/jnccn.2022.0001"},{"key":"2008_CR25","doi-asserted-by":"publisher","unstructured":"Qu Y, Feng X, Chen H, Tan F, Shao A, Pang J, \u2026 Shao K (2025) Multi-omics analyses reveal distinct molecular characteristics and transformation mechanisms of stage I-III micropapillary lung adenocarcinoma. J Pathol 266(2):204\u2013216. https:\/\/doi.org\/10.1002\/path.6416","DOI":"10.1002\/path.6416"},{"issue":"3","key":"2008_CR26","first-page":"138","volume":"8","author":"W Remmele","year":"1987","unstructured":"Remmele W, Stegner HE (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8(3):138\u2013140","journal-title":"Pathologe"},{"issue":"2","key":"2008_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1101\/gad.949802","volume":"16","author":"B Ren","year":"2002","unstructured":"Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA, Dynlacht BD (2002) E2F integrates cell cycle progression with DNA repair, replication, and G(2)\/M checkpoints. Genes Dev 16(2):245\u2013256. https:\/\/doi.org\/10.1101\/gad.949802","journal-title":"Genes Dev"},{"key":"2008_CR28","doi-asserted-by":"publisher","unstructured":"Sato Y, Yoshizato T, Shiraishi Y, Maekawa S, Okuno Y, Kamura T, \u2026 Ogawa S (2013) Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet 45(8):860\u2013867. https:\/\/doi.org\/10.1038\/ng.2699","DOI":"10.1038\/ng.2699"},{"issue":"4","key":"2008_CR29","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A (2017) Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168(4):707\u2013723. https:\/\/doi.org\/10.1016\/j.cell.2017.01.017","journal-title":"Cell"},{"issue":"1","key":"2008_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"key":"2008_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007530","author":"MF Soler","year":"2023","unstructured":"Soler MF, Abaurrea A, Azcoaga P, Araujo AM, Caffarel MM (2023) New perspectives in cancer immunotherapy: targeting IL-6 cytokine family. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2023-007530","journal-title":"J Immunother Cancer"},{"issue":"3","key":"2008_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2008_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41585-022-00654-6","volume":"20","author":"SK Tan","year":"2023","unstructured":"Tan SK, Hougen HY, Merchan JR, Gonzalgo ML, Welford SM (2023) Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets. Nat Rev Urol 20(1):48\u201360. https:\/\/doi.org\/10.1038\/s41585-022-00654-6","journal-title":"Nat Rev Urol"},{"issue":"10","key":"2008_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205660","volume":"13","author":"SP Verma","year":"2018","unstructured":"Verma SP, Das P (2018) Novel splicing in IGFN1 intron 15 and role of stable G-quadruplex in the regulation of splicing in renal cell carcinoma. PLoS ONE 13(10):e0205660. https:\/\/doi.org\/10.1371\/journal.pone.0205660","journal-title":"PLoS ONE"},{"key":"2008_CR35","doi-asserted-by":"publisher","unstructured":"Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, \u2026 Schreiber SL (2017) Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature 547(7664):453\u2013457. https:\/\/doi.org\/10.1038\/nature23007","DOI":"10.1038\/nature23007"},{"key":"2008_CR36","doi-asserted-by":"publisher","unstructured":"Wang L, He J, Chen J, Zeng X, Lu W, Qiu Y, \u2026 Lu Y (2025) Correlation between ADGRV1 expression and clinical pathological and prognostic features in breast cancer. Sci Rep 15(1):19738. https:\/\/doi.org\/10.1038\/s41598-025-04695-w","DOI":"10.1038\/s41598-025-04695-w"},{"key":"2008_CR37","doi-asserted-by":"publisher","unstructured":"Wu XQ, Shang Z, Xiong C, Xu WH, Dai B, Chen YL, \u2026 Ye DW (2024) Dissecting the Implications of Calumenin in Malignancy and Heterogeneity of the Microenvironment of clear cell renal cell carcinoma using multi-omics data. Phenomics 4(4):365\u2013378. https:\/\/doi.org\/10.1007\/s43657-024-00169-7","DOI":"10.1007\/s43657-024-00169-7"},{"key":"2008_CR38","doi-asserted-by":"publisher","unstructured":"Xu C, Liu F, Xiang G, Cao L, Wang S, Liu J, \u2026 Niu Y (2019) \u03b2-Catenin nuclear localization positively feeds back on EGF\/EGFR-attenuated AJAP1 expression in breast cancer. J Exp Clin Cancer Res 38(1):238. https:\/\/doi.org\/10.1186\/s13046-019-1252-6","DOI":"10.1186\/s13046-019-1252-6"},{"key":"2008_CR39","doi-asserted-by":"publisher","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, \u2026 Verhaak RG (2013). Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 4:2612. https:\/\/doi.org\/10.1038\/ncomms3612","DOI":"10.1038\/ncomms3612"},{"key":"2008_CR40","doi-asserted-by":"publisher","unstructured":"Yuan H, Yan M, Zhang G, Liu W, Deng C, Liao G, \u2026 Li X (2019) CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res 47(D1):D900-d908. https:\/\/doi.org\/10.1093\/nar\/gky939","DOI":"10.1093\/nar\/gky939"},{"key":"2008_CR41","doi-asserted-by":"publisher","unstructured":"Zhang M, Zhai W, Miao J, Cheng X, Luo W, Song W, \u2026 Gao WQ (2022) Single cell analysis reveals intra-tumour heterogeneity, microenvironment and potential diagnosis markers for clear cell renal cell carcinoma. Clin Transl Med 12(5):e713. https:\/\/doi.org\/10.1002\/ctm2.713","DOI":"10.1002\/ctm2.713"},{"key":"2008_CR42","doi-asserted-by":"publisher","unstructured":"Zhang J, Zi R, Hu P, Jiang Z, Lv Y, Zhang H, \u2026 Zhao L (2025) COL7A1 indicates crucial potential as a basal membrane-related prognostic biomarker and therapeutic target in lung adenocarcinoma. Front Pharmacol 16:1543193. https:\/\/doi.org\/10.3389\/fphar.2025.1543193","DOI":"10.3389\/fphar.2025.1543193"},{"key":"2008_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1671956","volume":"16","author":"D Zhou","year":"2025","unstructured":"Zhou D, Zhong C, Yang Q, Cui B, Wang Y (2025) Integration of bulk and single-cell transcriptomic data reveals a novel signature related to liver metastasis and basement membrane in pancreatic cancer. Front Immunol 16:1671956. https:\/\/doi.org\/10.3389\/fimmu.2025.1671956","journal-title":"Front Immunol"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-02008-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-026-02008-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-02008-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T01:46:23Z","timestamp":1786585583000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-026-02008-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2008"],"URL":"https:\/\/doi.org\/10.1007\/s10142-026-02008-6","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The collection and use of patient samples from the FAHZZU-ccRCC and Tongji-ccRCC cohorts were reviewed and approved by the Institutional Review Boards of the First Affiliated Hospital of Zhengzhou University (Approval No. 2024-KY-1579\u2013001) and Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (Approval No. 2021-S284). All participants provided written informed consent before being enrolled in the study. All procedures were conducted in accordance with the ethical standards of the institutional research committees and with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Clinical trial number: not applicable.","order":2,"name":"Ethics","label":"Trial registration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"225"}}